Podcast Episodes

Back to Search
Functional Ectopic Organs with LyGenesis' Michael Hufford, Ph.D.

We love to hear from our listeners. Send us a message.

LyGenesis is  developing a pipeline of allogeneic cell therapies using the lymph node as an in…

3 years ago

Short Long
View Episode
Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.

We love to hear from our listeners. Send us a message.

Today's episode of the Business of Biotech covers a lot of ground with Enzyvant CEO Bill Symon…

3 years ago

Short Long
View Episode
Next-Gen Nanobodies With MoonLake's Jorge Santos Da Silva, Ph.D.

We love to hear from our listeners. Send us a message.

The more we learn about inflammation and the complex cause/contributor/symptom roles it plays …

3 years ago

Short Long
View Episode
Lessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.

We love to hear from our listeners. Send us a message.

On the surface, the merger of Medsenic (a developer of arsenic salt formulations for therapeut…

3 years, 1 month ago

Short Long
View Episode
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono

We love to hear from our listeners. Send us a message.

Among a growing cluster of Pittsburgh biotechs, you'll find BlueSphere Bio, an early-stage com…

3 years, 1 month ago

Short Long
View Episode
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BoB@JPM
Elixirgen Therapeutics CEO Akihiro Ko joins the Business of Biotech fo…

3 years, 1 month ago

Short Long
View Episode
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BOB@JPM
Flagship Pioneering plucked Michael Severino, M.D. away from AbbVie to…

3 years, 1 month ago

Short Long
View Episode
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BOB@JPM
Bolt Biotherapeutics CEO Randall Schatzman, Ph.D. and CMO Edith Perez,…

3 years, 2 months ago

Short Long
View Episode
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BoB@JPM
The JP Morgan Healthcare Conference is a target-rich environment for c…

3 years, 2 months ago

Short Long
View Episode
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.

We love to hear from our listeners. Send us a message.

SPECIAL EDITION: BoB@JPM
The Business of Biotech podcast took to the streets of San Francisco d…

3 years, 2 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us